Disposition of 100000 shares by Nikita Shah of Amneal Pharmaceuticals, at 7.75 subject to Rule 16b-3

2DT Stock  EUR 7.30  0.05  0.69%   
Roughly 52% of Amneal Pharmaceuticals' investor base is interested to short. The analysis of current outlook of investing in Amneal Pharmaceuticals suggests that many traders are impartial regarding Amneal Pharmaceuticals' prospects. The current market sentiment, together with Amneal Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Amneal Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Amneal Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Amneal daily returns and investor perception about the current price of Amneal Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
  
Filed transaction by Amneal Pharmaceuticals, Class Officer: Executive Vice President. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 100000 class a common stock at 7.75 of Amneal Pharmaceuticals, by Nikita Shah on 14th of August 2024. This event was filed by Amneal Pharmaceuticals, Class with SEC on 2024-08-14. Statement of changes in beneficial ownership - SEC Form 4. Nikita Shah currently serves as chief human resource officer, executive vice president, strategic planning officer of Amneal Pharmaceuticals,

Amneal Pharmaceuticals Fundamental Analysis

We analyze Amneal Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amneal Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amneal Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash And Equivalents

Cash And Equivalents Comparative Analysis

Amneal Pharmaceuticals is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Amneal Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amneal Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Amneal Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Amneal Pharmaceuticals by comparing valuation metrics with similar companies.

Complementary Tools for Amneal Stock analysis

When running Amneal Pharmaceuticals' price analysis, check to measure Amneal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals is operating at the current time. Most of Amneal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Valuation
Check real value of public entities based on technical and fundamental data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges